British Airways has reopened its Newcastle contact centre after a £17 million refurbishment, which includes a new training ...
Back from ASH 2025, Dr Suchitra Sundaram reports on notable frontline CLL data. Time‑limited pirtobrutinib combined with venetoclax and obinutuzumab produced high rates of undetectable minimal ...
Venetoclax plus acalabrutinib becomes the first fully oral, fixed-duration option for treatment-naïve CLL, adding a differentiated targeted approach to frontline regimen selection. A defined treatment ...
Android phones now let you personalize how you appear on a call with the Calling Card feature in the Google Phone app. Instead of a basic contact photo, you can create a full screen visual card that ...
From electronic health records and blood tests to the stream of data from wearable devices, the amount of health information people generate is accelerating rapidly. Yet, many users struggle to ...
Many patients with chronic lymphocytic leukemia (CLL) are treated with two- or three-drug regimens, but for some patients just one drug may be enough. Particularly for older patients or those who are ...
Like a creature from a science fiction movie, chronic lymphocytic leukemia (CLL) can be a shape-shifter. In a small number of cases, patients with CLL will develop lymphoma, a complication known as ...
People with chronic lymphocytic leukemia (CLL) may have a higher risk of developing skin cancers, such as melanoma, than those without CLL. They may also have less positive outlooks if they develop ...
As a person with a chronic illness, I'm no stranger to bloodwork. I used to pore over my lab results, googling the various meanings, and trying not to panic when a test fell out of range. Function ...
Medical experts explain CLL’s slow progression and its impact on treatment timing, and they also discuss the watch-and-wait approach, patient concerns, and how to address anxiety about delaying ...
Health tech companies focused on preventive medicine and longevity are gaining interest from investors as well as consumers willing to pay out-of-pocket for personalized health services. Function ...